Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-004412
Filing Date
2024-06-04
Accepted
2024-06-04 16:31:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3260
  Complete submission text file 0001950047-24-004412.txt   5000
Mailing Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9226
Applied Therapeutics, Inc. (Subject) CIK: 0001697532 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38898 | Film No.: 241018645
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 26 NORTH EUCLID AVENUE PASADENA CA 91101
Business Address 26 NORTH EUCLID AVENUE PASADENA CA 91101 626-578-0777
Alexandria Venture Investments, LLC (Reporting) CIK: 0001722024 (see all company filings)

EIN.: 954844319 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144